We're asking the big market questions this week. Can you get a profit out of BHP this year? Will you ever make money on Pilbara Minerals and its lithium? And we ask St George Bank's former Chief Economist all about future rate cuts. Are they really now out of reach?
Joining Peter Switzer this week: Burman Invest's Julia Lee, Fairmont Equities' Michael Gable, Tribeca's Jun Bei Liu and Switzer's Paul Rickard.
Dr Ross Walker puts concerns about blood clotting from the coronavirus vaccine into perspective.
On this episode: FNArena's Rudi Filapek-Vandyck, EML Payments' Tom Cregan, Msquared Capital's Paul Myliotis and Coolabah Capital's Ying Yi Ann Cheng.
Join Peter Switzer and Paul Rickard for their weekly take on the latest money news.
On this episode: Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Rob Edgley from SelfWealth and Paul Rickard.
Dr Ross Walker believes there is a lot of misinformation around alcohol and gives you the reasons why he doesn’t necessarily agree with an Australian study on alcohol consumption.
On this week's show: Switzer's Paul Rickard, Rex's John Sharp, CoreLogic's Tim Lawless and Coolabah Capital's Ying Yi Ann Cheng.
Tune in to the latest live episode of Mad about Money with Peter Switzer and Paul Rickard.
Roger Montgomery from Montgomery Investment Management, Warren Hebard from iSelect, Michael Knox from Morgans and Paul Rickard from Switzer join the show.
Join Peter Switzer and Paul Rickard for the latest live episode of Mad about Money.
Peter Switzer speaks to Julia Lee from Burman Invest, Adam Dawes from Shaw and Partners, Michael Gable from Fairmont Equities and Paul Rickard from Switzer.
Dr Ross Walker discusses research on basal cell cancer treatment that is similar to the COVID-19 vaccine.
Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox